HeliosX is a rapidly growing health technology organization committed to enhancing the accessibility, quality, and affordability of healthcare. Founded in 2013, HeliosX operates multiple health tech brands, including Dermatica, RocketRx, MedExpress, and ZipHealth, delivering over 2.2 million digital healthcare consultations across the UK, US, and EU. The company utilizes a vertically integrated clinical and pharmacy platform to provide a seamless, personalized healthcare experience that empowers patients to obtain prescription medications and advanced skincare treatments efficiently. HeliosX places a strong emphasis on innovation, being entirely bootstrapped and achieving profitability without external funding, reflecting its focus on sustainable growth. With its in-house clinical teams and manufacturing capabilities, HeliosX is well-positioned for ongoing expansion, aiming to impact the lives of even more people globally.